Correct management and low rate of contagiousness of healthcare workers in a University Hospital in Southern Italy: from contact tracing to serological investigation

Main Article Content

Raffaele Squeri
Antonio Levita
Rosanna Intelisano
Gaetano Bruno Costa
Giuseppe Mancuso
Loredana Grasso
Smeralda D'Amato
Francesco Mazzitelli
Andrea Squeri
Angelina Midiri
Carmelo Biondo
Domenica Alesci
Vincen Bonaccorso
Alessandra Bitto
Cristina Genovese


management, healthcare workers, COVID-19, SARS-CoV-2, symptoms


The COVID-19 epidemic, which began in Wuhan in December 2019, quickly spread all over the world, leading in a few months to a high number of deaths also in healthcare workers. The purpose of the study is to a) describe the importance of a correct management of SARS-CoV-2 infections; b) report the number of positive healthcare workers after the epidemic phase and to describe their socio-characteristics data, the main methods of transmission and the symptoms; c) to report the seroconversion rate of healthcare workers  (HCWs). The study was conducted from March 9, 2020 to June 19, 2020 in three phases:1) in a first phase, we implemented the guidelines to be followed for patient care in our hospital; 2) in a second phase, we provided the epidemiological investigation/contact tracing of HCWs; 3)  we collected swabs on all healthcare workers and we also performed serological investigation. The number of healthcare workers under surveillance is of 2611 subjects and, of these, only 0.65% contracted COVID-19. In particular, 70.6% of these have been infected in the healthcare setting, 11, 8% in the family and 17.6% returning from high risk areas. Ultimately, only 0.1% of HCWs dedicated to the treatment of COVID-19 patients contracted the infection (one was asymptomatic). Only 2% of HCWS were positive for serological investigation.


Download data is not yet available.
Abstract 459 | PDF Downloads 186


1. Data on COVID. Johns Hopkins.
2. Spiteri G, Fielding J, Diercke M, et al. First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020. Euro Surveill. 2020;25(9):2000178. doi:10.2807/1560-7917.ES.2020.25.9.2000178
3. Yong SEF, Anderson DE, Wei WE, et al. Connecting clusters of COVID-19: an epidemiological and serological investigation [published online ahead of print, 2020 Apr 21]. Lancet Infect Dis. 2020;S1473-3099(20)30273-5. doi:10.1016/S1473-3099(20)30273-5
4. Capobianchi MR, Rueca M, Messina F, et al. Molecular characterization of SARS-CoV-2 from the first case of COVID-19 in Italy [published online ahead of print, 2020 Mar 27]. Clin Microbiol Infect. 2020;26(7):954-956. doi:10.1016/j.cmi.2020.03.025
5. Romagnani P, Gnone G, Guzzi F, et al. The COVID-19 infection: lessons from the Italian experience [published online ahead of print, 2020 May 29]. J Public Health Policy. 2020;1-7. doi:10.1057/s41271-020-00229-y
6. Odone A, Delmonte D, Scognamiglio T, Signorelli C. COVID-19 deaths in Lombardy, Italy: data in context [published correction appears in Lancet Public Health. 2020 Jun;5(6):e315]. Lancet Public Health. 2020;5(6):e310. doi:10.1016/S2468-2667(20)30099-2
7. Signorelli C, Scognamiglio T, Odone A. COVID-19 in Italy: impact of containment measures and prevalence estimates of infection in the general population . Acta Bio Med [Internet]. 2020Apr.10;91(3-S):175-9.
8. second-meeting-of-the-international-health-regulation. Available on
9. Ordinanza 21 febbraio 2020. Ulteriori misure profilattiche contro la diffusione della malattia infettiva COVID-19. (20A01220). (G.U. Serie Generale , n. 44 del 22 febbraio 2020
10. ORDINANZA 20 marzo 2020. Ulteriori misure urgenti in materia di contenimento e gestione dell'emergenza epidemiologica da COVID-19, applicabili sull'intero territorio nazionale. (20A01797) (GU Serie Generale n.73 del 20-03-2020)
11. Documento relativo ai criteri per sottoporre soggetti clinicamente asintomatici alla ricerca d’infezione da SARS-CoV-2 attraverso tampone rino-faringeo e test diagnostico
12. DECRETO-LEGGE 9 marzo 2020 , n. 14 . Disposizioni urgenti per il potenziamento del Servizio sanitario nazionale in relazione all’emergenza COVID-19.
13. Ordinanza contingibile e urgente n. 7 del 20.03.2020 Ulteriori misure per la prevenzione e gestione dell’emergenza epidemiologica da Covid-2019. Ordinanza ai sensi dell’art.32, comma 3, della legge 23 dicembre 1978, n. 833 in materia di igiene e sanità pubblica. Regione Sicilia.
15. Corman VM, Eckerle I, Bleicker T et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020;25(3):pii=2000045.
16. Reusken CBEM, Broberg EK, Haagmans B et al. Laboratory readiness and response for novel coronavirus (2019-nCoV) in expert laboratories in 30 EU/EEA countries, January 2020. Euro Surveill. 2020;25(6):2000082. doi:10.2807/1560-7917.ES.2020.25.6.2000082
17. circolare del Ministero della salute prot. n. 5443 del 22 febbraio 2020
18. Protocollo metodologico per un’indagine di siero-prevalenza sul SARS-CoV-2 condotta dal Ministero della salute e dall’ISTAT Decreto Legge 10 maggio 2020 n.30
19. Park T, Sang-Yeop L, Seil K, et al. Spike protein binding prediction with neutralizing antibodies of SARS-CoV-2 bioRxiv 2020.02.22.951178; doi:
20. Diggle DJ Estimating Prevalence Using an Imperfect Test, Epidemiology Research International, 2011
21. Document of the Ministry of Health of 28/02/2020 concerning the definition of "Patient cured of Covid-19"
22. Circular of the Ministry of Health of May 9, 2020
23. Grech V. Unknown unknowns - COVID-19 and potential global mortality. Early Hum Dev. 2020;144:105026. doi:10.1016/j.earlhumdev.2020.105026
24. Sorveglianza Integrata COVID-19 in Italia. Available on
25. Chang D, Xu H, Rebaza A, Sharma L, Dela Cruz CS. Protecting health-care workers from subclinical coronavirus infection. The Lancet Respiratory Medicine, Volume 8, Issue 3, e13.
26. Chou R, Dana T, Buckley DI, Selph S, Fu R, Totten AM. Epidemiology of and Risk Factors for Coronavirus Infection in Health Care Workers [published online ahead of print, 2020 May 5]. Ann Intern Med. 2020;M20-1632. doi:10.7326/M20-1632
27. Chan JF, Yuan S, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514-523. doi:10.1016/S0140-6736(20)30154-9
28. Grant R, Malik MR, Elkholy A, Van Kerkhove MD. A Review of Asymptomatic and Subclinical Middle East Respiratory Syndrome Coronavirus Infections. Epidemiol Rev. 2019;41(1):69-81. doi:10.1093/epirev/mxz009
29. Wilder-Smith A, Teleman MD, Heng BH, Earnest A, Ling AE, Leo YS. Asymptomatic SARS coronavirus infection among healthcare workers, Singapore. Emerg Infect Dis. 2005;11(7):1142-1145. doi:10.3201/eid1107.041165
30. Haveri A, Smura T, Kuivanen S, et al. Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020. Euro Surveill. 2020;25(11):2000266. doi:10.2807/1560-7917.ES.2020.25.11.2000266
31. Maltezou HC, Poland GA. Vaccination policies for healthcare workers in Europe. Vaccine. 2014;32(38):4876-4880. doi:10.1016/j.vaccine.2013.10.046
32. Chen L, Hao G. The role of angiotensin-converting enzyme 2 in coronaviruses/influenza viruses and cardiovascular disease [published online ahead of print, 2020 Apr 8]. Cardiovasc Res. 2020;cvaa093. doi:10.1093/cvr/cvaa093
33. Costantino C, Ledda C, Genovese C et al. Immunization Status against Measles of Health-Care Workers Operating at Three Sicilian University Hospitals: An Observational Study..Vaccines (Basel). 2019 Nov 3;7(4):175. doi: 10.3390/vaccines7040175.
34. Squeri R, Di Pietro A, La Fauci V, Genovese C. Healthcare workers' vaccination at European and Italian level: a narrative review. Acta Biomed. 2019 Sep 13;90(9-S):45-53. doi: 10.23750/abm.v90i9-S.8703.
35. Genovese C , La Fauci V , Costa GB et al . A potential outbreak of measles and chickenpox among healthcare workers in a university hospital. EMBJ 2019,14 (10) 045–048
36. Genovese C, Picerno IAM, Trimarchi G et al.Vaccination coverage in healthcare workers: a multicenter cross-sectional study in Italy. J Prev Med Hyg. 2019 Mar 29;60(1):E12-E17. doi: 10.15167/2421-4248/jpmh2019.60.1.1097. eCollection 2019 Mar.
37. Squeri R, La Fauci V, Picerno IAM et al.Evaluation of Vaccination Coverages in the Health Care Workers of a University Hospital in Southern Italy. Ann Ig. 2019 Mar-Apr;31(2 Supple 1):13-24. doi: 10.7416/ai.2019.2273.
38. Montagna MT, Mascipinto S, Pousis C, et al Knowledge, experiences, and attitudes toward Mantoux test among medical and health professional students in Italy: a cross-sectional study. Ann Ig. 2018 Sep-Oct;30(5 Supple 2):86-98. doi: 10.7416/ai.2018.2253.
39. La Fauci V, Riso R, Facciolà A, Merlina V, Squeri R.
Surveillance of microbiological contamination and correct use of protective lead garments.Ann Ig. 2016 Sep-Oct;28(5):360-6. doi: 10.7416/ai.2016.2116.
40. La Fauci V, Costa GB, Arena A, Ventura Spagnolo E, Genovese C, Palamara MA, Squeri R. Trend of MDR-microorganisms isolated from the biological samples of patients with HAI and from the surfaces around that patient. New Microbiol. 2018 Jan;41(1):42-46. Epub 2018 Jan 9.
41. Ventura Spagnolo, E., Stassi, C., Mondello, C., Zerbo, S., Milone, L., Argo, A. Forensic microbiology applications: A systematic review Legal Medicine 2019; 36: 73-80
42. Spagnolo, E.V., Mondello, C., Stassi, C, Baldino, G., D’Aleo, F. Conte, M. Argo, A, Zerbo, S. Forensic microbiology: A case series analysis EMBJ 2019; 14 (27): 117-121
43. Spagnolo, E.V. Cannavò, G., Mondello, C., Cardia, L., Bartoloni, G., Cardia, G. Unexpected death for takayasu aortitis associated with coronary ostial stenosis American Journal of Forensic Medicine and Pathology 2015; 36(2): 88-90

Most read articles by the same author(s)